Titoli del Settore Sanitario
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 3044 |  CV CapsoVision, Inc. - Common Stock | 6.90 USD | +1.77% | +3.29% | -8.00% | +38.00% | 344.75 M USD | ||
| 3048 |  SOPH SOPHiA GENETICS SA - Ordinary Shares | 4.99 USD | -1.19% | +0.40% | -7.25% | +66.33% | 341.75 M USD | ||
| 3049 |  RZLT Rezolute, Inc. - Common Stock | 3.61 USD | +9.39% | +10.74% | +8.73% | -10.86% | 347.62 M USD | ||
| 3052 |  FENC Fennec Pharmaceuticals Inc. - Common Stock | 9.87 USD | -0.60% | -1.00% | +50.46% | +21.10% | 342.85 M USD | ||
| 3053 |  NMRA Neumora Therapeutics, Inc. - Common Stock | 1.82 USD | -1.62% | -4.71% | -25.41% | +163.77% | 337.22 M USD | ||
| 3054 |  IRD Opus Genetics, Inc. - Common Stock | 0.04 USD | -5.50% | -99.07% | -99.22% | -98.92% | 3.35 M USD | ||
| 3065 |  RCKT Rocket Pharmaceuticals, Inc. - Common Stock | 3.02 USD | -1.63% | +0.67% | -14.93% | +20.80% | 329.76 M USD | ||
| 3092 |  LCTX Lineage Cell Therapeutics, Inc. Common Stock | 1.31 USD | -2.24% | -0.76% | -12.08% | -23.84% | 326.58 M USD | ||
| 3093 |  ZTS Zoetis Inc. Class A Common Stock | 0.78 USD | -99.00% | -99.03% | -99.31% | -99.47% | 326.54 M USD | ||
| 3094 |  MASS 908 Devices Inc. - Common Stock | 8.63 USD | +2.62% | +17.41% | +27.47% | +58.35% | 326.33 M USD | ||
| 3095 |  EDIT Editas Medicine, Inc. - Common Stock | 3.33 USD | -3.76% | +38.17% | +15.63% | +89.20% | 326.03 M USD | ||
| 3106 |  HUMA Humacyte, Inc. - Common Stock | 1.45 USD | +11.54% | +38.10% | +66.67% | -46.30% | 321.93 M USD | ||
| 3110 |  ABEO Abeona Therapeutics Inc. - Common Stock | 5.63 USD | -2.93% | +2.55% | +3.87% | -10.78% | 320.88 M USD | ||
| 3116 |  FATE Fate Therapeutics, Inc. - Common Stock | 2.74 USD | -3.52% | +21.24% | +79.08% | +112.40% | 319.37 M USD | ||
| 3128 |  DMAC DiaMedica Therapeutics Inc. - Common Stock | 5.84 USD | -2.50% | -2.83% | -5.19% | +43.14% | 314.68 M USD | ||
| 3129 |  TENX Tenax Therapeutics, Inc. - Common Stock | 11.97 USD | +9984.25% | -3.08% | -6.48% | +58.54% | 317.51 M USD | ||
| 3137 |  SLN Silence Therapeutics Plc - American Depository Share | 6.53 USD | -5.36% | +3.82% | -9.43% | +10.87% | 308.44 M USD | ||
| 3138 |  PRLD Prelude Therapeutics Incorporated - Common Stock | 3.82 USD | -2.55% | -7.73% | -20.75% | +329.21% | 304.25 M USD | ||
| 3147 |  ORGO Organogenesis Holdings Inc. - Class A | 2.36 USD | +9082.88% | -11.61% | -7.09% | -44.99% | 303.67 M USD | ||
| 3154 |  CARL Carlsmed, Inc. - Common Stock | 11.10 USD | -2.80% | -10.12% | +18.34% | -26.00% | 301.75 M USD |
Notizie Titoli del Settore Sanitario
Perché il titolo Fulcrum Therapeutics crolla nel dopo-borsa?
Abivax inverte la rotta: titolo giù del 40% nonostante dati positivi
Wolfe Research avvia copertura su Repligen con rating outperform
Wolfe Research avvia la copertura di Waters con rating Outperform
Wolfe Research avvia copertura su Stevanato con rating Outperform
Wolfe Research avvia copertura su Thermo Fisher con rating Outperform
Wolfe Research avvia la copertura di Danaher con rating Peerperform
Gainers Titoli del Settore Sanitario
 EWTX Edgewise Therapeutics, Inc. - Common Stock | 40.26 | +11685.71% |
 MBIO Mustang Bio, Inc. - Common Stock | 0.77 | +11392.54% |
 PMI Picard Medical, Inc. Common Stock | 0.17 | +11233.33% |
 HYPD Hyperion DeFi, Inc. - Common Stock | 3.86 | +10928.57% |
 CLYM Climb Bio, Inc. - Common Stock | 11.80 | +10666.42% |
 KPRX Kiora Pharmaceuticals, Inc. - Common Stock | 2.87 | +10608.96% |
 ADGM Adagio Medical Holdings, Inc - Common Stock | 0.77 | +10594.44% |
 ORIC Oric Pharmaceuticals, Inc. - Common Stock | 8.98 | +10527.22% |
